en41-ugr7c hiv vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01827397)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- en41-ugr7c hiv vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01827397 | Phase 1 | Apr 1, 2013 | European Commission, PX'Therapeutics, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Commission | Government | 1 | 0 | 1 | 2013 |
| PX'Therapeutics | For profit | 1 | 1 | 1 | 2013 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1